Evidence map›Paper›PMID 27065774›Full record

ArticleEXCLI journal2016

QSAR study of HCV NS5B polymerase inhibitors using the genetic algorithm-multiple linear regression (GA-MLR).

Hamid Rafiei, Marziyeh Khanzadeh, Shahla Mozaffari, Mohammad Hassan Bostanifar, Zhila Mohajeri Avval, Reza Aalizadeh, Eslam Pourbasheer

Abstract read
In one paragraph

Article in EXCLI journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A non-conformational QSAR study for plant-derived larvicides against Zika Aedes aegypti L. vector.Environmental science and pollution research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hamid RafieiDepartment of Chemistry, Dashtestan Branch, Islamic Azad University, Dashtestan, Iran.
Marziyeh KhanzadehDepartment of Chemistry, Payame Noor University (PNU), P. O. Box 19395-3697, Tehran, Iran.
Shahla MozaffariDepartment of Chemistry, Payame Noor University (PNU), P. O. Box 19395-3697, Tehran, Iran.
Mohammad Hassan BostanifarDepartment of Chemistry, Dashtestan Branch, Islamic Azad University, Dashtestan, Iran.
Zhila Mohajeri AvvalDepartment of Chemistry, Payame Noor University (PNU), P. O. Box 19395-3697, Tehran, Iran.
Reza AalizadehLaboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Eslam PourbasheerDepartment of Chemistry, Payame Noor University (PNU), P. O. Box 19395-3697, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative structure-activity relationship (QSAR) study has been employed for predicting the inhibitory activities of the Hepatitis C virus (HCV) NS5B polymerase inhibitors . A data set consisted of 72 compounds was selected, and then different types of molecular descriptors were calculated. The whole data set was split into a training set (80 % of the dataset) and a test set (20 % of the dataset) using principle component analysis. The stepwise (SW) and the genetic algorithm (GA) techniques were used as variable selection tools. Multiple linear regression method was then used to linearly correlate the selected descriptors with inhibitory activities. Several validation technique including leave-one-out and leave-group-out cross-validation, Y-randomization method were used to evaluate the internal capability of the derived models. The external prediction ability of the derived models was further analyzed using modified r(2), concordance correlation coefficient values and Golbraikh and Tropsha acceptable model criteria's. Based on the derived results (GA-MLR), some new insights toward molecular structural requirements for obtaining better inhibitory activity were obtained.

Indexed as

genetic algorithmsHCVmultiple linear regressionQSAR

Identifiers

PMID27065774
PMCPMC4822051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.